全文获取类型
收费全文 | 4696篇 |
免费 | 344篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 168篇 |
妇产科学 | 54篇 |
基础医学 | 721篇 |
口腔科学 | 147篇 |
临床医学 | 503篇 |
内科学 | 852篇 |
皮肤病学 | 46篇 |
神经病学 | 361篇 |
特种医学 | 559篇 |
外科学 | 489篇 |
综合类 | 34篇 |
预防医学 | 219篇 |
眼科学 | 32篇 |
药学 | 524篇 |
中国医学 | 1篇 |
肿瘤学 | 286篇 |
出版年
2023年 | 22篇 |
2022年 | 33篇 |
2021年 | 48篇 |
2020年 | 44篇 |
2019年 | 49篇 |
2018年 | 70篇 |
2017年 | 66篇 |
2016年 | 89篇 |
2015年 | 98篇 |
2014年 | 128篇 |
2013年 | 179篇 |
2012年 | 209篇 |
2011年 | 219篇 |
2010年 | 153篇 |
2009年 | 128篇 |
2008年 | 235篇 |
2007年 | 205篇 |
2006年 | 201篇 |
2005年 | 186篇 |
2004年 | 170篇 |
2003年 | 152篇 |
2002年 | 173篇 |
2001年 | 158篇 |
2000年 | 157篇 |
1999年 | 133篇 |
1998年 | 100篇 |
1997年 | 115篇 |
1996年 | 108篇 |
1995年 | 100篇 |
1994年 | 101篇 |
1993年 | 90篇 |
1992年 | 94篇 |
1991年 | 80篇 |
1990年 | 81篇 |
1989年 | 94篇 |
1988年 | 93篇 |
1987年 | 79篇 |
1986年 | 73篇 |
1985年 | 68篇 |
1984年 | 46篇 |
1983年 | 40篇 |
1982年 | 46篇 |
1981年 | 29篇 |
1980年 | 37篇 |
1979年 | 29篇 |
1978年 | 31篇 |
1977年 | 36篇 |
1976年 | 33篇 |
1975年 | 47篇 |
1974年 | 21篇 |
排序方式: 共有5043条查询结果,搜索用时 0 毫秒
61.
Viljoen M Karlsson MO Meyers TM Gous H Dandara C Rheeders M 《European journal of clinical pharmacology》2012,68(4):339-347
Objective
To investigate the influence of CYP2B6 516G>T polymorphism, as a covariate, and of interoccasion variability (IOV) on the oral clearance (CL/F) of efavirenz (EFV) in treatment-naïve black South African children over a period of 24 months post-antiretroviral therapy (ART) initiation.Methods
HIV-infected black children (n?=?60, aged 3–16 years), with no prior exposure to ART, eligible to commence ART and attending an outpatient clinic were enrolled into this study. Blood samples were taken at mid-dose interval at 1, 3, 6, 12, 18 and 24 months post-ART initiation. EFV plasma samples were determined with an adapted and validated LC/MS/MS method. Genotyping of the CYP2B6 G516T single nucleotide polymorphism (SNP) was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). NONMEM was used for the population pharmacokinetic modelling.Results
EFV concentrations below 1 μg/mL accounted for 18% (116/649), EFV concentrations >4 μg/mL accounted for 29.5% (192/649) and concentrations within the therapeutic range (1–4 μg/mL) represented 52.5% (341/649) of all the samples determined. The covariates age, weight and CYP2B6 G516Tgenotype were included in the final model with population estimates for CL/F determined as 2.46, 4.60 and 7.33 L/h for the T/T, G/T and G/G genotype groups respectively.Conclusions
The inclusion of both age and weight to predict accurate EFV CL values for the respective genotype groups within this paediatric population was required, whereas the addition of gender and body surface area did not improve the predictions. The importance of introducing IOV in a PK model for a longitudinal study with sparsely collected data was again highlighted by this investigation.62.
Ylva Dahlin Redfors Sara Olaison Jan Karlsson Johan Hellgren Claes Möller 《International journal of audiology》2015,54(2):63-69
Objectives: The aims of the study were to assess health-related quality of life and hearing-related disability in subjects with otosclerosis 30 years after surgery. Design: An observational study was performed. Medical records were reviewed, a clinical examination as well as audiometric assessments were performed. Generic health-related quality of life was assessed by the SF-36v2 and hearing disability by a shortened version of SSQ (speech spatial and qualities of hearing scale). Study sample: Sixty-five individuals, who had undergone stapedectomy in 1977-79 at a tertiary referral center. Results: Generic health-related quality of life according to SF-36 subscale scores was comparable to that of an age- and sex-matched reference population. The SF-36 mental component summary score (MCS) was, however, significantly better than that of the reference population. The mental and physical summary component scores correlated significantly to hearing disability measured by the SSQ but not to hearing impairment. Hearing disability was displayed in all SSQ sub-scores, especially in more complex listening situations and in the localization of sounds. Conclusions: This study shows that individuals with otosclerosis, 30 years after surgery, have a good generic health-related quality of life, despite moderate to severe hearing loss and significant hearing disabilities. 相似文献
63.
64.
We report a case of intrauterine fetal death at term with a possible association to an oral bacterium, Rothia dentocariosa. A healthy primiparous woman was admitted at term with an intrauterine fetal death after an uncomplicated pregnancy. R. dentocariosa was found in the fetal blood culture. 相似文献
65.
66.
67.
68.
69.
Elin M. Svensson Francesca Aweeka Jeong-Gun Park Florence Marzan Kelly E. Dooley Mats O. Karlsson 《Antimicrobial agents and chemotherapy》2013,57(6):2780-2787
Safe, effective concomitant treatment regimens for tuberculosis (TB) and HIV infection are urgently needed. Bedaquiline (BDQ) is a promising new anti-TB drug, and efavirenz (EFV) is a commonly used antiretroviral. Due to EFV''s induction of cytochrome P450 3A4, the metabolic enzyme responsible for BDQ biotransformation, the drugs are expected to interact. Based on data from a phase I, single-dose pharmacokinetic study, a nonlinear mixed-effects model characterizing BDQ pharmacokinetics and interaction with multiple-dose EFV was developed. BDQ pharmacokinetics were best described by a 3-compartment disposition model with absorption through a dynamic transit compartment model. Metabolites M2 and M3 were described by 2-compartment models with clearance of BDQ and M2, respectively, as input. Impact of induction was described as an instantaneous change in clearance 1 week after initialization of EFV treatment and estimated for all compounds. The model predicts average steady-state concentrations of BDQ and M2 to be reduced by 52% (relative standard error [RSE], 3.7%) with chronic coadministration. A range of models with alternative structural assumptions regarding onset of induction effect and fraction metabolized resulted in similar estimates of the typical reduction and did not offer a markedly better fit to data. Simulations to investigate alternative regimens mitigating the estimated interaction effect were performed. The results suggest that simple adjustments of the standard regimen during EFV coadministration can prevent reduced exposure to BDQ without increasing exposures to M2. However, exposure to M3 would increase. Evaluation in clinical trials of adjusted regimens is necessary to ensure appropriate dosing for HIV-infected TB patients on an EFV-based regimen. 相似文献